VEGF (Bevacizumab Biosimilar) Antibodies
(VEGF (Bevacizumab Biosimilar))
This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms. [provided by RefSeq, Jul 2008].
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Recommended VEGF (Bevacizumab Biosimilar) Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
ELISA
Validations
- (1)
Cat. No.
ABIN7093077
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
FACS, in vivo
Validations
Cat. No.
ABIN7200653
Quantity
1 mg
Datasheet
Datasheet
Reactivity
Human
Application
FACS, ELISA, WB, BR, IP
Validations
Cat. No.
ABIN7487763
Quantity
200 μg
Datasheet
Datasheet
Synonyms and alternative names related to VEGF (Bevacizumab Biosimilar)
vascular endothelial growth factor A (VEGFA), MVCD1, VEGF, VPFProtein level used designations for VEGF (Bevacizumab Biosimilar)
- vascular permeability factor
You are here:
